HomeGALT • NASDAQ
add
Galectin Therapeutics Inc. Common Stock
Previous close
$1.30
Day range
$1.29 - $1.36
Year range
$0.73 - $3.17
Market cap
83.54M USD
Avg Volume
160.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.90M | -18.15% |
Net income | -9.63M | 16.17% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.43M | -68.45% |
Total assets | 9.53M | -63.20% |
Total liabilities | 121.79M | 25.59% |
Total equity | -112.26M | — |
Shares outstanding | 63.29M | — |
Price to book | -0.72 | — |
Return on assets | -146.12% | — |
Return on capital | 6,000.76% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -9.63M | 16.17% |
Cash from operations | -7.69M | 36.48% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -7.69M | -265.27% |
Free cash flow | -6.18M | 31.12% |
About
Founded
2000
Headquarters
Website
Employees
15
